WHAT´S NEW in Ulcerative Colititis & Crohn's Disease?

In this section you will be able to identify the new content uploaded regularly .

Duration 1:28

Prof. Subrata Ghosh 

Science Foundation Ireland Research Professor, Chair and Head of Dept of Medicine, University College Cork, Ireland

 

"How to align histology with FCP"

Duration 1:35

Dr. Joana Torres 

Gastroenterology Assistant at Hospital Beatriz Ângelo, Loures,

Portugal.

 

"How to interpret FCP values symptomatic UC"

Duration 6:34

Dr. Joana Torres 

Gastroenterology Assistant at Hospital Beatriz Ângelo, Loures,

Portugal.

 

"How to interpret FCP values asymptomatic CD"

Duration 2:02

Dr. Joana Torres 

Gastroenterology Assistant at Hospital Beatriz Ângelo, Loures,

Portugal.

 

"How to interpret FCP values symptomatic CD"

Duration 1:03

Dr. Joana Torres 

Gastroenterology Assistant at Hospital Beatriz Ângelo, Loures,

Portugal.

 

"Commentary video on UC patient "

Duration 2:08

Dr. Joana Torres 

Gastroenterology Assistant at Hospital Beatriz Ângelo, Loures,

Portugal.

 

"Commentary video on CD patient "

Duration 0:35

Prof. Raja Atreya  

Senior Physician and Head of the Inflammatory Bowel Disease (IBD) Unit, Outpatient Clinic, and Clinical Study Centre at the University Hospital Erlangen, Germany

 

How to decide when to switch therapies "

Duration 1:03

Prof. Raja Atreya  

Senior Physician and Head of the Inflammatory Bowel Disease (IBD) Unit, Outpatient Clinic, and Clinical Study Centre at the University Hospital Erlangen, Germany

 

How to treat special IBD populations"

Duration 1:00

Prof. Raja Atreya  

Senior Physician and Head of the Inflammatory Bowel Disease (IBD) Unit, Outpatient Clinic, and Clinical Study Centre at the University Hospital Erlangen, Germany

 

How to Discuss vaccination with your patients"

Duration 3:10

Prof. Remo Panaccione   

Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Canada.

 

"How to recognise loss of response"

Duration 3:10

Prof. Remo Panaccione   

Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Canada.

 

"How to Discuss benefit: risk of treatments video"

Duration 0:40

Prof. Remo Panaccione   

Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Canada.

 

"Commentary video UC patient - Remo Panaccione "

Duration 2:10

Prof. James Lindsay    

Professor of Inflammatory Bowel Disease and a Consultant Gastroenterologist at The Royal London Hospital, England.

 

"How to Differentiate between targets, endpoints and goals"

Duration 0:58

Prof. James Lindsay    

Professor of Inflammatory Bowel Disease and a Consultant Gastroenterologist at The Royal London Hospital, England.

 

"Commentary video on UC patient"

Duration 1:40

Prof. James Lindsay    

Professor of Inflammatory Bowel Disease and a Consultant Gastroenterologist at The Royal London Hospital, England.

 

"Commentary video on CD patient"

Duration 0:55

Prof. Subrata Ghosh     

Science Foundation Ireland Research Professor, Chair and Head of Dept of Medicine, University College Cork, Ireland

 

"Commentary video on UC patient"

Duration 0:58

Prof. Subrata Ghosh     

Science Foundation Ireland Research Professor, Chair and Head of Dept of Medicine, University College Cork, Ireland

 

"Commentary video on CD patient"

Duration 2:25

Dr. Reena Khanna ay     

Associate Professor of Medicine at the University of Western Ontario, Canada.

 

"How to discuss fertility and family planning"

Duration 3:25

Dr. Peter Bossuyt     

Gastroenterologist at the IBD clinic in the Imelda General Hospital in Bonheiden, Belgium. 

 

"How to act on endoscopic response, but not remission"


 

For Oman HCPs.

Department of Pharmacovigilance & Drug information.

Directorate General of pharmaceutical affairs and Drug control.

Ministry of health, Sultanate of Oman

Phone Nos:: 22357687 / 22357686

Fax: 22358489

Email: [email protected]

Website:www.moh.gov.om

 

This website is intended for Gulf Healthcare Professionals

AbbVie Biopharmaceuticals GmbH.

 

Suite 2901, U Bora Tower,Business Bay, Dubai, UAE

PO Box:: 118052

OFFICE : +971 4 5506100

FAX: +971 4 5506101

•Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.

[email protected] or Hotline: 00971564135746

JAKa-BH-00004-MC